We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.79B
AUM Growth
-$293M
Cap. Flow
-$236M
Cap. Flow %
-8.47%
Top 10 Hldgs %
28.68%
Holding
277
New
13
Increased
48
Reduced
113
Closed
20

Sector Composition

1 Healthcare 18.64%
2 Industrials 16.35%
3 Technology 15.12%
4 Consumer Discretionary 10.07%
5 Financials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GG
126
DELISTED
Goldcorp Inc
GG
$2.96M 0.11%
182,670
BP icon
127
BP
BP
$107B
$2.95M 0.11%
116,057
-12,217
-10% -$308K
CAT icon
128
Caterpillar
CAT
$411B
$2.91M 0.1%
37,970
-900
-2% -$60.4K
VZ icon
129
Verizon
VZ
$184B
$2.83M 0.1%
52,353
+100
+0.2% +$5K
VRN
130
DELISTED
Veren
VRN
$2.81M 0.1%
203,350
-2,000
-1% -$23.1K
TGT icon
131
Target
TGT
$64B
$2.66M 0.1%
32,275
-42,750
-57% -$3.23M
DHI icon
132
D.R. Horton
DHI
$43B
$2.64M 0.09%
87,375
-600
-0.7% -$16.5K
MO icon
133
Altria Group
MO
$124B
$2.58M 0.09%
41,112
-9,950
-19% -$602K
WHR icon
134
Whirlpool
WHR
$2.51B
$2.5M 0.09%
13,835
-17,250
-55% -$2.57M
WFC icon
135
Wells Fargo
WFC
$267B
$2.38M 0.09%
49,241
-5,400
-10% -$264K
GLW icon
136
Corning
GLW
$136B
$2.34M 0.08%
111,900
LOW icon
137
Lowe's Companies
LOW
$119B
$2.27M 0.08%
29,975
-250
-0.8% -$17.6K
OMED
138
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.13M 0.08%
210,403
WT icon
139
WisdomTree
WT
$3.08B
$2.08M 0.07%
182,050
-3,163,200
-95% -$38M
META icon
140
Meta Platforms (Facebook)
META
$1.61T
$1.92M 0.07%
16,815
+800
+5% +$84.4K
UHT
141
Universal Health Realty Income Trust
UHT
$605M
$1.8M 0.06%
32,083
NVS icon
142
Novartis
NVS
$294B
$1.78M 0.06%
27,450
-670
-2% -$45.6K
BMY icon
143
Bristol-Myers Squibb
BMY
$125B
$1.7M 0.06%
26,527
+200
+0.8% +$12.6K
SPY icon
144
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$1.67M 0.06%
+8,112
New +$1.58M
HP icon
145
Helmerich & Payne
HP
$3.37B
$1.64M 0.06%
27,980
-10,545
-27% -$557K
COP icon
146
ConocoPhillips
COP
$139B
$1.63M 0.06%
40,533
-18,441
-31% -$701K
AGIO icon
147
Agios Pharmaceuticals
AGIO
$2.33B
$1.61M 0.06%
39,640
CEF icon
148
Sprott Physical Gold and Silver Trust
CEF
$7.29B
$1.58M 0.06%
132,100
PLD icon
149
Prologis
PLD
$140B
$1.58M 0.06%
35,800
-241,625
-87% -$9.7M
T icon
150
AT&T
T
$153B
$1.48M 0.05%
50,160

Similar funds

Cannell & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Cannell & Co held 277 positions worth $2.79B, down 9.5% from $3.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cannell & Co withdrew a net $236M in Q1 2016, closing 20 positions and reducing 113 holdings. Its most notable exit was Analog Devices, an estimated $82.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cannell & Co opened a new position in Sabre worth $51.8M.

  • Cannell & Co's largest Q1 2016 buy was Sabre: 1,789,900 shares worth $51.8M.
  • Cannell & Co added most to Time Warner Inc in Q1 2016, an estimated $49.4M increase.
  • Cannell & Co's biggest Q1 2016 reduction was XPO, cutting an estimated $64.4M.
  • Cannell & Co fully exited Analog Devices in Q1 2016, selling an estimated $82.2M.
  • Cannell & Co's ten largest holdings make up 29% of its $2.79B portfolio in Q1 2016.
  • Cannell & Co opened 13 new positions and closed 20 in Q1 2016.
  • Cannell & Co's portfolio value fell 9.5% quarter-over-quarter to $2.79B.

Based on Cannell & Co's 13F filing for Q1 2016, filed 11 May 2016.